Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,609,000 | 7,903,000 | 9,469,000 | 13,393,000 | 12,405,000 |
| Marketable Securities | 411,000 | 532,000 | 225,000 | 1,035,000 | 290,000 |
| Receivables | 8,150,000 | 8,480,000 | 8,251,000 | 7,533,000 | 7,099,000 |
| Inventories | 5,939,000 | 5,747,000 | 5,743,000 | 5,913,000 | 5,610,000 |
| Other current assets | 3,155,000 | 3,031,000 | 2,759,000 | 2,607,000 | 20,256,000 |
| TOTAL | $31,264,000 | $25,693,000 | $26,447,000 | $30,481,000 | $45,660,000 |
| Non-Current Assets | |||||
| PPE Net | 9,749,000 | 9,254,000 | 9,200,000 | 9,514,000 | 9,044,000 |
| Investments And Advances | 2,192,000 | 2,126,000 | 2,582,000 | 2,812,000 | 2,122,000 |
| Intangibles | 52,832,000 | 53,009,000 | 49,335,000 | 50,220,000 | 49,834,000 |
| Other Non-Current Assets | 7,487,000 | 7,423,000 | 6,770,000 | 6,918,000 | 6,037,000 |
| TOTAL | $72,260,000 | $71,812,000 | $67,887,000 | $69,464,000 | $67,037,000 |
| Total Assets | $103,524,000 | $97,505,000 | $94,334,000 | $99,945,000 | $112,697,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,566,000 | 7,532,000 | 8,339,000 | 6,175,000 | 5,458,000 |
| Accounts payable and accrued liabilities | 4,087,000 | 4,146,000 | 4,062,000 | 4,926,000 | 3,870,000 |
| Other current liabilities | 15,067,000 | 13,783,000 | 15,012,000 | 13,166,000 | 13,974,000 |
| TOTAL | $28,132,000 | $27,612,000 | $29,288,000 | $26,390,000 | $48,393,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 23,750,000 | 19,663,000 | 17,191,000 | 18,436,000 | 18,068,000 |
| Other Non-Current Liabilities | 5,989,000 | 5,872,000 | 5,788,000 | 6,121,000 | 5,532,000 |
| TOTAL | $31,951,000 | $27,991,000 | $25,290,000 | $26,805,000 | $26,059,000 |
| Total Liabilities | $60,083,000 | $55,603,000 | $54,578,000 | $53,195,000 | $74,452,000 |
| Shareholders' Equity | |||||
| Common Shares | 793,000 | 793,000 | 793,000 | 825,000 | 825,000 |
| Retained earnings | 42,564,000 | 40,965,000 | 38,899,000 | 45,883,000 | 37,371,000 |
| Other shareholders' equity | 124,000 | 169,000 | 81,000 | 83,000 | 81,000 |
| TOTAL | $43,441,000 | $41,902,000 | $39,756,000 | $46,750,000 | $38,245,000 |
| Total Liabilities And Equity | $103,524,000 | $97,505,000 | $94,334,000 | $99,945,000 | $112,697,000 |